Urinary β-2 Microglobulin Levels Sensitively Altered in an Osteomalacia Patient Receiving Add-on Adefovir Dipivoxil Therapy for Hepatitis B Virus Infection

Intern Med. 2016;55(12):1599-603. doi: 10.2169/internalmedicine.55.6301. Epub 2016 Jun 15.

Abstract

Adefovir dipivoxil (ADV) is effective for hepatitis B virus (HBV) infection; however, ADV may provoke renal injury resulting in osteomalacia, and this side effect is seldom recognized until bone fractures emerge. We herein present a 66-year-old woman with HBV infection who received ADV for 6 years. Although she exhibited no sign of bone fractures, her urinary β-2 microglobulin (β2MG) level increased to 83,837 μg/L and scintigraphy revealed minimal fractures of the third rib. ADV was subsequently reduced and her urinary β2MG rapidly fell to 3,637 μg/L. Conversely, her urinary N-acetyl-β-D-glucosaminidase, and serum phosphate, alkaline phosphatase levels did not respond.

Publication types

  • Case Reports

MeSH terms

  • Adenine / adverse effects
  • Adenine / analogs & derivatives*
  • Aged
  • Antiviral Agents / therapeutic use*
  • Female
  • Hepatitis B, Chronic / diagnosis*
  • Hepatitis B, Chronic / drug therapy*
  • Humans
  • Japan
  • Organophosphonates / adverse effects*
  • Osteomalacia / chemically induced*
  • Osteomalacia / diagnosis
  • Osteomalacia / therapy*
  • beta 2-Microglobulin / urine*

Substances

  • Antiviral Agents
  • Organophosphonates
  • beta 2-Microglobulin
  • Adenine
  • adefovir dipivoxil